NCLT approves demerger of pharma business from Piramal Enterprises

Ajay Piramal, chairperson of PEL said the company is on track to achieve the completion of demerger and separate listing of PPL by the third quarter of the current financial year. Subsequently, in connection with the composite scheme of arrangement, the company has obtained consent from RBI, SEBI, stock exchanges, and clearances from its creditors and equity shareholders.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/AbMlkuV
via IFTTT